` Comparison: 4AJ0 vs NOVN - Alpha Spread

4AJ0
vs
NOVN

Over the past 12 months, 4AJ0 has outperformed NOVN, delivering a return of +35% compared to the NOVN's +28% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
4AJ0
NOVN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

4AJ0 Intrinsic Value
26.77 EUR
Overvaluation 8%
Intrinsic Value
Price
NOVN Intrinsic Value
107.28 CHF
Overvaluation 15%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
ALK-Abello A/S
F:4AJ0
29 EUR
Novartis AG
SIX:NOVN
125.88 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
4AJ0, NOVN

4AJ0
NOVN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
ALK-Abello A/S
Revenue
Novartis AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
4AJ0, NOVN

4AJ0
NOVN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
ALK-Abello A/S
F:4AJ0
Novartis AG
SIX:NOVN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

4AJ0
65.9%
NOVN
75.8%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novartis AG

Operating Margin

4AJ0
24.2%
NOVN
33.2%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novartis AG

Net Margin

4AJ0
18.1%
NOVN
24.8%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novartis AG

FCF Margin

4AJ0
3.6%
NOVN
27.1%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novartis AG

ROE

4AJ0
19.6%
NOVN
31%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novartis AG

ROA

4AJ0
14.1%
NOVN
13.1%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novartis AG

ROIC

4AJ0
15.9%
NOVN
17.8%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novartis AG

ROCE

4AJ0
22.5%
NOVN
23.8%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novartis AG

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
4AJ0, NOVN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
4AJ0, NOVN

Loading
4AJ0
NOVN
Difference
www.alphaspread.com

Performance By Year
4AJ0, NOVN

Loading
4AJ0
NOVN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 4AJ0 to other stocks
LLY
Eli Lilly and Co
JNJ
Johnson & Johnson
ROG
Roche Holding AG
AZN
AstraZeneca PLC
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account